IPSEN (EPA:IPN) | WebDisclosure

Basculer en Français

9472	Companies
185369	Keywords
117719	Articles
99261	Press releases

Home
Companies
IPSEN

BRIEF

published on 12/01/2025 at 07:05, 3 days 23 hours ago

Ipsen annonce le décès d'Henri Beaufour

Développement Commercial Ipsen Membre Du Conseil D'administration Henri Beaufour Héritage De L'entreprise
BRIEF

published on 12/01/2025 at 07:05, 3 days 23 hours ago

Ipsen Announces the Passing of Henri Beaufour

Business Development Board Member Ipsen Henri Beaufour Corporate Legacy
PRESS RELEASE

published on 12/01/2025 at 07:00, 3 days 23 hours ago

Ipsen annonce avec une profonde tristesse le décès de Henri Beaufour, membre de son conseil d'administration issu de la famille fondatrice
Ipsen annonce le décès de Henri Beaufour, membre du conseil d'administration et représentant de la famille fondatrice. L'équipe présente ses condoléances et réaffirme son engagement envers le groupe Ipsen

Conseil D'administration Décès Ipsen Condoléances Famille Fondatrice
PRESS RELEASE

published on 12/01/2025 at 07:00, 3 days 23 hours ago

Ipsen mourns the passing of Henri Beaufour, a founding family Board member
Ipsen announces the passing of Henri Beaufour, a founding family Board member, with heartfelt condolences. Beech Tree and Highrock affirm support for Ipsen's future development

Development Condolences Ipsen Henri Beaufour Founding Family
BRIEF

published on 10/22/2025 at 07:10, 1 month 13 days ago

Ipsen Reports Strong Sales and Raises 2025 Guidance

Oncology Pipeline Therapeutic Areas 2025 Financial Guidance Ipsen Sales Growth ImCheck Acquisition
BRIEF

published on 10/22/2025 at 07:10, 1 month 13 days ago

Ipsen annonce de solides ventes et relève ses prévisions pour 2025

Pipeline En Oncologie Orientations Financières Pour 2025 Croissance Des Ventes D'Ipsen Acquisition D'ImCheck Domaines Thérapeutiques
PRESS RELEASE

published on 10/22/2025 at 07:05, 1 month 13 days ago

Ipsen delivers strong sales in the first nine months of 2025 and further upgrades its full-year guidance
Ipsen reports strong sales growth in first nine months of 2025, upgrades full-year guidance, and announces acquisition of ImCheck Therapeutics. Financial results and pipeline updates detailed

Acquisition Sales Growth Upgrades Full-year Guidance Ipsen
PRESS RELEASE

published on 10/22/2025 at 07:05, 1 month 13 days ago

Ipsen enregistre une forte dynamique commerciale au cours des neuf premiers mois de l'année 2025 et revoit à la hausse ses prévisions pour l'exercice en cours
PRESS RELEASE

published on 10/07/2025 at 18:30, 1 month 28 days ago

IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 40 - 2025
PRESS RELEASE

published on 10/07/2025 at 18:30, 1 month 28 days ago

IPSEN - Buy-back programme - Art 5 of MAR - Week 40 - 2025

1 2 ... 6

Accesswire

Published on 12/05/2025 at 02:35, 4 hours 4 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 4 hours 9 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 5 hours 39 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 34 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 39 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 03:30, 3 hours 8 minutes ago

CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 48 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 13 minutes ago

Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 24 minutes ago

Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 28 minutes ago

SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance

Les Echos

Published on 12/04/2025 at 18:14, 12 hours 24 minutes ago

Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 12 hours 39 minutes ago

Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 12 hours 39 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 54 minutes ago

Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 12 hours 54 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL

View all LES ECHOS COMFI WIRE